h 11B6
Alternative Names: [225Ac]hu11B6; h11B6; hu11B6Latest Information Update: 28 Feb 2023
At a glance
- Originator Diaprost
- Developer Diaprost; Undisclosed Company
- Class Antineoplastics; Diagnostic agents; Imaging agents; Monoclonal antibodies; Radioisotopes; Radiopharmaceutical diagnostics; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters; Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Prostate cancer
Most Recent Events
- 28 Feb 2023 No recent reports of development identified for clinical-Phase-Unknown development in Prostate-cancer in Sweden (Parenteral)
- 28 Feb 2023 No recent reports of development identified for clinical-Phase-Unknown development in Prostate-cancer(Diagnosis) in Sweden (Parenteral)
- 21 Jan 2020 Clinical trials in Prostate cancer (Diagnosis) in Sweden (Parenteral)